good news and bad news about Vioxx

The good news and bad news about Vioxx is creating questions.

GI safety. Vioxx (rofecoxib) reduces the risk of GI bleeding and perforations by 50% compared to naproxen.

Vioxx is the first COX-2 inhibitor with proof acceptable to the FDA that it causes fewer serious ulcers than a traditional NSAID.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote